title: [A cross-sectional study on the use of statin among patients with atherosclerotic ischemic stroke in China].
abstract: OBJECTIVE
  To investigate the degree and determinants of the use on statin among patients with atherosclerotic ischemic stroke in China.
  
  
  METHODS
  In the context of an international multi-center clinical trial being undertaken in China, 5585 patients with atherosclerotic ischemic stroke were screened in 39 prestigious hospitals in 10 cities. The characteristics collected through electronic questionnaire were described and analyzed.
  
  
  RESULTS
  All the screened patients had indications for statins. Among those, 60% of the patients had a history from 3 months to 2 years of suffering from stroke. However, up to 80% of the patients were not using statins when screened. Even in those with statins, about 1/4 of the patients took statins for much shorter period than the history of stroke. The proportion using statins among IS patients with CHD was 4 times more than in those without CHD. Simvastatin and Atorvastatin were most commonly used.
  
  
  CONCLUSIONS
  Statins were greatly underused for secondary prevention among patients with atherosclerotic ischemic stroke in China. There was a large gap between evidence and practice. It remains a major challenge for healthcare professionals and policy makers to tackle this problem more positively.
authors.affiliation: China Oxford Centre for International Health Research Cardiovascular Institute & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, China; On Behalf of HPS2-THRIVE China Collaborative Group. Email: lixin.jiang@fwoxford.org.
authors.forename: Li-Xin
authors.initials: LX
authors.lastname: Jiang
authors.forename: Xi
authors.initials: X
authors.lastname: Li
authors.forename: Jing
authors.initials: J
authors.lastname: Li
authors.forename: Fang
authors.initials: F
authors.lastname: Feng
authors.forename: Yi-Ping
authors.initials: YP
authors.lastname: Chen
authors.forename: Zheng-Ming
authors.initials: ZM
authors.lastname: Chen
authors.forename: Landray
authors.initials: L
authors.lastname: Martin
authors.forename: Armitage
authors.initials: A
authors.lastname: Jane
mesh_terms: D000069059:Atorvastatin; D002681:China; D003430:Cross-Sectional Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D020521:Stroke / Q000188:drug therapy
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000069059:Atorvastatin